{"transactions":[{"id":725470,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35140,"kind":"person","name":"Shawver Laura","position":1,"cik":"0001551891","reported_name":"Shawver Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-26T20:15:08.000Z","date":"2026-06-24","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest in full on the earlier of June 24, 2027 or the date of the Issuer's 2027 annual meeting of stockholders, which date has not been set by the Issuer's Board of Directors."}],"balance_after":30000,"derivative":{"exercise_price":10.54,"expiration_date":"2036-06-23","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001551891-26-000002","document":"form4-06262026_040601.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000155189126000002/form4-06262026_040601.xml","form_type":"4"}},{"id":1100212,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35140,"kind":"person","name":"Shawver Laura","position":1,"cik":"0001551891","reported_name":"Shawver Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-27T20:30:06.000Z","date":"2025-06-25","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest in full on the earlier of June 25, 2026 or the date of the Issuer's 2026 annual meeting of stockholders, which date has not been set by the Issuer's Board of Directors."}],"balance_after":30000,"derivative":{"exercise_price":17.26,"expiration_date":"2035-06-24","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001415889-25-018382","document":"form4-06272025_040603.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588925018382/form4-06272025_040603.xml","form_type":"4"}},{"id":1175617,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35140,"kind":"person","name":"Shawver Laura","position":1,"cik":"0001551891","reported_name":"Shawver Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-04-08T20:45:04.000Z","date":"2025-04-07","kind":"exercise","planned":true,"acquired":false,"shares":27493,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Immediately exercisable."}],"balance_after":24062,"derivative":{"exercise_price":4.85,"expiration_date":"2032-01-31","underlying":"Common Stock","underlying_shares":27493},"source":{"system":"sec-edgar","filing":"0001415889-25-010395","document":"form4-04082025_040401.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588925010395/form4-04082025_040401.xml","form_type":"4"}},{"id":1175616,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35140,"kind":"person","name":"Shawver Laura","position":1,"cik":"0001551891","reported_name":"Shawver Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-04-08T20:45:04.000Z","date":"2025-04-07","kind":"exercise","planned":true,"acquired":false,"shares":22509,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Immediately exercisable."}],"balance_after":51555,"derivative":{"exercise_price":4.85,"expiration_date":"2032-01-31","underlying":"Common Stock","underlying_shares":22509},"source":{"system":"sec-edgar","filing":"0001415889-25-010395","document":"form4-04082025_040401.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588925010395/form4-04082025_040401.xml","form_type":"4"}},{"id":1175615,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35140,"kind":"person","name":"Shawver Laura","position":1,"cik":"0001551891","reported_name":"Shawver Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-04-08T20:45:04.000Z","date":"2025-04-07","kind":"sale","planned":true,"acquired":false,"shares":50002,"price":12.301,"value":615074.602,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares reported on this Form 4 were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $12.301 and the range of prices were between $12.0063 and $12.64. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":210346,"source":{"system":"sec-edgar","filing":"0001415889-25-010395","document":"form4-04082025_040401.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588925010395/form4-04082025_040401.xml","form_type":"4"}},{"id":1175614,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35140,"kind":"person","name":"Shawver Laura","position":1,"cik":"0001551891","reported_name":"Shawver Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-04-08T20:45:04.000Z","date":"2025-04-07","kind":"exercise","planned":true,"acquired":true,"shares":27493,"price":4.85,"value":133341.05,"ownership":{"direct":true},"balance_after":260348,"source":{"system":"sec-edgar","filing":"0001415889-25-010395","document":"form4-04082025_040401.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588925010395/form4-04082025_040401.xml","form_type":"4"}},{"id":1175613,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35140,"kind":"person","name":"Shawver Laura","position":1,"cik":"0001551891","reported_name":"Shawver Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-04-08T20:45:04.000Z","date":"2025-04-07","kind":"exercise","planned":true,"acquired":true,"shares":22509,"price":4.85,"value":109168.65,"ownership":{"direct":true},"balance_after":232855,"source":{"system":"sec-edgar","filing":"0001415889-25-010395","document":"form4-04082025_040401.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588925010395/form4-04082025_040401.xml","form_type":"4"}},{"id":1217410,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35140,"kind":"person","name":"Shawver Laura","position":1,"cik":"0001551891","reported_name":"Shawver Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-07T22:12:15.000Z","date":"2025-03-06","kind":"exercise","planned":true,"acquired":false,"shares":49600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Immediately exercisable."}],"balance_after":74064,"derivative":{"exercise_price":4.85,"expiration_date":"2032-01-31","underlying":"Common Stock","underlying_shares":49600},"source":{"system":"sec-edgar","filing":"0001415889-25-007438","document":"form4-03072025_100311.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588925007438/form4-03072025_100311.xml","form_type":"4"}},{"id":1217409,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35140,"kind":"person","name":"Shawver Laura","position":1,"cik":"0001551891","reported_name":"Shawver Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-07T22:12:15.000Z","date":"2025-03-05","kind":"exercise","planned":true,"acquired":false,"shares":400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Immediately exercisable."}],"balance_after":123664,"derivative":{"exercise_price":4.85,"expiration_date":"2032-01-31","underlying":"Common Stock","underlying_shares":400},"source":{"system":"sec-edgar","filing":"0001415889-25-007438","document":"form4-03072025_100311.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588925007438/form4-03072025_100311.xml","form_type":"4"}},{"id":1217408,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35140,"kind":"person","name":"Shawver Laura","position":1,"cik":"0001551891","reported_name":"Shawver Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-07T22:12:15.000Z","date":"2025-03-06","kind":"sale","planned":true,"acquired":false,"shares":49600,"price":11.2106,"value":556045.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares reported on this Form 4 were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $11.2106 and the range of prices were between $11.00 and $11.55. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":210346,"source":{"system":"sec-edgar","filing":"0001415889-25-007438","document":"form4-03072025_100311.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588925007438/form4-03072025_100311.xml","form_type":"4"}},{"id":1217407,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35140,"kind":"person","name":"Shawver Laura","position":1,"cik":"0001551891","reported_name":"Shawver Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-07T22:12:15.000Z","date":"2025-03-06","kind":"exercise","planned":true,"acquired":true,"shares":49600,"price":4.85,"value":240560.0,"ownership":{"direct":true},"balance_after":259946,"source":{"system":"sec-edgar","filing":"0001415889-25-007438","document":"form4-03072025_100311.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588925007438/form4-03072025_100311.xml","form_type":"4"}},{"id":1217406,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35140,"kind":"person","name":"Shawver Laura","position":1,"cik":"0001551891","reported_name":"Shawver Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-07T22:12:15.000Z","date":"2025-03-05","kind":"sale","planned":true,"acquired":false,"shares":400,"price":11,"value":4400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares reported on this Form 4 were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2024."}],"balance_after":210346,"source":{"system":"sec-edgar","filing":"0001415889-25-007438","document":"form4-03072025_100311.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588925007438/form4-03072025_100311.xml","form_type":"4"}},{"id":1217405,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35140,"kind":"person","name":"Shawver Laura","position":1,"cik":"0001551891","reported_name":"Shawver Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-07T22:12:15.000Z","date":"2025-03-05","kind":"exercise","planned":true,"acquired":true,"shares":400,"price":4.85,"value":1940.0,"ownership":{"direct":true},"balance_after":210746,"source":{"system":"sec-edgar","filing":"0001415889-25-007438","document":"form4-03072025_100311.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588925007438/form4-03072025_100311.xml","form_type":"4"}},{"id":1284847,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35140,"kind":"person","name":"Shawver Laura","position":1,"cik":"0001551891","reported_name":"Shawver Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-04T21:35:06.000Z","date":"2025-02-03","kind":"exercise","planned":true,"acquired":false,"shares":40936,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Immediately exercisable."}],"balance_after":124064,"derivative":{"exercise_price":4.85,"expiration_date":"2032-01-31","underlying":"Common Stock","underlying_shares":40936},"source":{"system":"sec-edgar","filing":"0001415889-25-002955","document":"form4-02042025_040201.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588925002955/form4-02042025_040201.xml","form_type":"4"}},{"id":1284846,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35140,"kind":"person","name":"Shawver Laura","position":1,"cik":"0001551891","reported_name":"Shawver Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-04T21:35:06.000Z","date":"2025-02-03","kind":"exercise","planned":true,"acquired":false,"shares":9064,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Immediately exercisable."}],"balance_after":0,"derivative":{"exercise_price":3.15,"expiration_date":"2032-05-01","underlying":"Common Stock","underlying_shares":9064},"source":{"system":"sec-edgar","filing":"0001415889-25-002955","document":"form4-02042025_040201.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588925002955/form4-02042025_040201.xml","form_type":"4"}},{"id":1284845,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35140,"kind":"person","name":"Shawver Laura","position":1,"cik":"0001551891","reported_name":"Shawver Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-02-04T21:35:06.000Z","date":"2025-02-03","kind":"sale","planned":true,"acquired":false,"shares":50000,"price":12.3113,"value":615565.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares reported on this Form 4 were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $12.3113 and the range of prices were between $11.9732 and $12.76. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":210346,"source":{"system":"sec-edgar","filing":"0001415889-25-002955","document":"form4-02042025_040201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588925002955/form4-02042025_040201.xml","form_type":"4"}},{"id":1284844,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35140,"kind":"person","name":"Shawver Laura","position":1,"cik":"0001551891","reported_name":"Shawver Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-02-04T21:35:06.000Z","date":"2025-02-03","kind":"exercise","planned":true,"acquired":true,"shares":40936,"price":4.85,"value":198539.6,"ownership":{"direct":true},"balance_after":260346,"source":{"system":"sec-edgar","filing":"0001415889-25-002955","document":"form4-02042025_040201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588925002955/form4-02042025_040201.xml","form_type":"4"}},{"id":1284843,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35140,"kind":"person","name":"Shawver Laura","position":1,"cik":"0001551891","reported_name":"Shawver Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-02-04T21:35:06.000Z","date":"2025-02-03","kind":"exercise","planned":true,"acquired":true,"shares":9064,"price":3.15,"value":28551.6,"ownership":{"direct":true},"balance_after":219410,"source":{"system":"sec-edgar","filing":"0001415889-25-002955","document":"form4-02042025_040201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588925002955/form4-02042025_040201.xml","form_type":"4"}},{"id":1308059,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35140,"kind":"person","name":"Shawver Laura","position":1,"cik":"0001551891","reported_name":"Shawver Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-07T23:24:27.000Z","date":"2025-01-06","kind":"exercise","planned":true,"acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Immediately exercisable."}],"balance_after":9064,"derivative":{"exercise_price":3.15,"expiration_date":"2032-05-01","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001415889-25-001053","document":"form4-01072025_110124.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588925001053/form4-01072025_110124.xml","form_type":"4"}},{"id":1308058,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35140,"kind":"person","name":"Shawver Laura","position":1,"cik":"0001551891","reported_name":"Shawver Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-07T23:24:27.000Z","date":"2025-01-06","kind":"sale","planned":true,"acquired":false,"shares":50000,"price":11.1013,"value":555065.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares reported on this Form 4 were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $11.1013 and the range of prices were between $11.00 and $11.43. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":210346,"source":{"system":"sec-edgar","filing":"0001415889-25-001053","document":"form4-01072025_110124.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588925001053/form4-01072025_110124.xml","form_type":"4"}},{"id":1308057,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35140,"kind":"person","name":"Shawver Laura","position":1,"cik":"0001551891","reported_name":"Shawver Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-07T23:24:27.000Z","date":"2025-01-06","kind":"exercise","planned":true,"acquired":true,"shares":50000,"price":3.15,"value":157500.0,"ownership":{"direct":true},"balance_after":260346,"source":{"system":"sec-edgar","filing":"0001415889-25-001053","document":"form4-01072025_110124.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588925001053/form4-01072025_110124.xml","form_type":"4"}},{"id":1342932,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35140,"kind":"person","name":"Shawver Laura","position":1,"cik":"0001551891","reported_name":"Shawver Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-05T02:40:07.000Z","date":"2024-12-04","kind":"exercise","planned":true,"acquired":false,"shares":14772,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Immediately exercisable."}],"balance_after":59064,"derivative":{"exercise_price":3.15,"expiration_date":"2032-05-01","underlying":"Common Stock","underlying_shares":14772},"source":{"system":"sec-edgar","filing":"0001415889-24-028350","document":"form4-12042024_091203.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924028350/form4-12042024_091203.xml","form_type":"4"}},{"id":1342931,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35140,"kind":"person","name":"Shawver Laura","position":1,"cik":"0001551891","reported_name":"Shawver Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-05T02:40:07.000Z","date":"2024-12-03","kind":"exercise","planned":true,"acquired":false,"shares":62378,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Immediately exercisable."}],"balance_after":73836,"derivative":{"exercise_price":3.15,"expiration_date":"2032-05-01","underlying":"Common Stock","underlying_shares":62378},"source":{"system":"sec-edgar","filing":"0001415889-24-028350","document":"form4-12042024_091203.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924028350/form4-12042024_091203.xml","form_type":"4"}},{"id":1342930,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35140,"kind":"person","name":"Shawver Laura","position":1,"cik":"0001551891","reported_name":"Shawver Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-05T02:40:07.000Z","date":"2024-12-03","kind":"exercise","planned":true,"acquired":false,"shares":25606,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Immediately exercisable."}],"balance_after":0,"derivative":{"exercise_price":1.27,"expiration_date":"2030-04-28","underlying":"Common Stock","underlying_shares":25606},"source":{"system":"sec-edgar","filing":"0001415889-24-028350","document":"form4-12042024_091203.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924028350/form4-12042024_091203.xml","form_type":"4"}},{"id":1342929,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35140,"kind":"person","name":"Shawver Laura","position":1,"cik":"0001551891","reported_name":"Shawver Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-05T02:40:07.000Z","date":"2024-12-02","kind":"exercise","planned":true,"acquired":false,"shares":67616,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F7","text":"Due to a clerical error, the total number of shares subject to this option grant was underreported by one share on the Reporting Person's Form 3 and is corrected on this filing."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Immediately exercisable."}],"balance_after":0,"derivative":{"exercise_price":1.27,"expiration_date":"2030-04-28","underlying":"Common Stock","underlying_shares":67616},"source":{"system":"sec-edgar","filing":"0001415889-24-028350","document":"form4-12042024_091203.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924028350/form4-12042024_091203.xml","form_type":"4"}},{"id":1342928,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35140,"kind":"person","name":"Shawver Laura","position":1,"cik":"0001551891","reported_name":"Shawver Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-05T02:40:07.000Z","date":"2024-12-02","kind":"exercise","planned":true,"acquired":false,"shares":29628,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Immediately exercisable."}],"balance_after":25606,"derivative":{"exercise_price":1.27,"expiration_date":"2030-04-28","underlying":"Common Stock","underlying_shares":29628},"source":{"system":"sec-edgar","filing":"0001415889-24-028350","document":"form4-12042024_091203.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924028350/form4-12042024_091203.xml","form_type":"4"}},{"id":1342927,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35140,"kind":"person","name":"Shawver Laura","position":1,"cik":"0001551891","reported_name":"Shawver Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-05T02:40:07.000Z","date":"2024-12-04","kind":"sale","planned":true,"acquired":false,"shares":14772,"price":13.7496,"value":203109.0912,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares reported on this Form 4 were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The weighted average sale price for the transaction reported was $13.7496 and the range of prices were between $13.39 and $14.00. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":210346,"source":{"system":"sec-edgar","filing":"0001415889-24-028350","document":"form4-12042024_091203.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924028350/form4-12042024_091203.xml","form_type":"4"}},{"id":1342926,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35140,"kind":"person","name":"Shawver Laura","position":1,"cik":"0001551891","reported_name":"Shawver Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-05T02:40:07.000Z","date":"2024-12-04","kind":"exercise","planned":true,"acquired":true,"shares":14772,"price":3.15,"value":46531.8,"ownership":{"direct":true},"balance_after":225118,"source":{"system":"sec-edgar","filing":"0001415889-24-028350","document":"form4-12042024_091203.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924028350/form4-12042024_091203.xml","form_type":"4"}},{"id":1342925,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35140,"kind":"person","name":"Shawver Laura","position":1,"cik":"0001551891","reported_name":"Shawver Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-05T02:40:07.000Z","date":"2024-12-03","kind":"sale","planned":true,"acquired":false,"shares":87984,"price":13.2626,"value":1166896.5984,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares reported on this Form 4 were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The weighted average sale price for the transaction reported was $13.2626 and the range of prices were between $12.92 and $13.62. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":210346,"source":{"system":"sec-edgar","filing":"0001415889-24-028350","document":"form4-12042024_091203.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924028350/form4-12042024_091203.xml","form_type":"4"}},{"id":1342924,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35140,"kind":"person","name":"Shawver Laura","position":1,"cik":"0001551891","reported_name":"Shawver Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-05T02:40:07.000Z","date":"2024-12-03","kind":"exercise","planned":true,"acquired":true,"shares":62378,"price":3.15,"value":196490.7,"ownership":{"direct":true},"balance_after":298330,"source":{"system":"sec-edgar","filing":"0001415889-24-028350","document":"form4-12042024_091203.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924028350/form4-12042024_091203.xml","form_type":"4"}},{"id":1342923,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35140,"kind":"person","name":"Shawver Laura","position":1,"cik":"0001551891","reported_name":"Shawver Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-05T02:40:07.000Z","date":"2024-12-03","kind":"exercise","planned":true,"acquired":true,"shares":25606,"price":1.27,"value":32519.62,"ownership":{"direct":true},"balance_after":235952,"source":{"system":"sec-edgar","filing":"0001415889-24-028350","document":"form4-12042024_091203.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924028350/form4-12042024_091203.xml","form_type":"4"}},{"id":1342922,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35140,"kind":"person","name":"Shawver Laura","position":1,"cik":"0001551891","reported_name":"Shawver Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-05T02:40:07.000Z","date":"2024-12-02","kind":"sale","planned":true,"acquired":false,"shares":901,"price":14.3417,"value":12921.8717,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares reported on this Form 4 were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The weighted average sale price for the transaction reported was $14.3417 and the range of prices were between $14.2761 and $14.375. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":210346,"source":{"system":"sec-edgar","filing":"0001415889-24-028350","document":"form4-12042024_091203.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924028350/form4-12042024_091203.xml","form_type":"4"}},{"id":1342921,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35140,"kind":"person","name":"Shawver Laura","position":1,"cik":"0001551891","reported_name":"Shawver Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-05T02:40:07.000Z","date":"2024-12-02","kind":"sale","planned":true,"acquired":false,"shares":96343,"price":13.5539,"value":1305823.3877,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares reported on this Form 4 were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $13.5539 and the range of prices were between $13.27 and $14.20. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":211247,"source":{"system":"sec-edgar","filing":"0001415889-24-028350","document":"form4-12042024_091203.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924028350/form4-12042024_091203.xml","form_type":"4"}},{"id":1342920,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35140,"kind":"person","name":"Shawver Laura","position":1,"cik":"0001551891","reported_name":"Shawver Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-05T02:40:07.000Z","date":"2024-12-02","kind":"exercise","planned":true,"acquired":true,"shares":29628,"price":1.27,"value":37627.56,"ownership":{"direct":true},"balance_after":307590,"source":{"system":"sec-edgar","filing":"0001415889-24-028350","document":"form4-12042024_091203.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924028350/form4-12042024_091203.xml","form_type":"4"}},{"id":1342919,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35140,"kind":"person","name":"Shawver Laura","position":1,"cik":"0001551891","reported_name":"Shawver Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-05T02:40:07.000Z","date":"2024-12-02","kind":"exercise","planned":true,"acquired":true,"shares":67616,"price":1.27,"value":85872.32,"ownership":{"direct":true},"balance_after":277962,"source":{"system":"sec-edgar","filing":"0001415889-24-028350","document":"form4-12042024_091203.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924028350/form4-12042024_091203.xml","form_type":"4"}},{"id":1470701,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35140,"kind":"person","name":"Shawver Laura","position":1,"cik":"0001551891","reported_name":"Shawver Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-24T21:00:19.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest in full on the earlier of June 20, 2025 or the date of the Issuer's 2025 annual meeting of stockholders, which date has not been set by the Issuer's Board of Directors."}],"balance_after":40000,"derivative":{"exercise_price":7.73,"expiration_date":"2034-06-19","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001415889-24-018016","document":"form4-06242024_050616.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924018016/form4-06242024_050616.xml","form_type":"4"}},{"id":1490173,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":35140,"kind":"person","name":"Shawver Laura","position":1,"cik":"0001551891","reported_name":"Shawver Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-06T00:05:23.000Z","date":"2024-06-03","kind":"grant","planned":false,"acquired":true,"shares":102225,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 3, 2024 with respect to 102,225 shares of the Issuer's common stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the grant date."}],"balance_after":102225,"derivative":{"exercise_price":6.79,"expiration_date":"2034-06-02","underlying":"Common Stock","underlying_shares":102225},"source":{"system":"sec-edgar","filing":"0000950170-24-069559","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000095017024069559/ownership.xml","form_type":"4"}},{"id":1789238,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35140,"kind":"person","name":"Shawver Laura","position":1,"cik":"0001551891","reported_name":"Shawver Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-09-06T00:04:41.000Z","date":"2023-09-01","kind":"exercise","planned":true,"acquired":false,"shares":97003,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Immediately exercisable."}],"balance_after":55235,"derivative":{"exercise_price":1.27,"expiration_date":"2030-04-28","underlying":"Common Stock","underlying_shares":97003},"source":{"system":"sec-edgar","filing":"0001209191-23-048254","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000120919123048254/doc4.xml","form_type":"4"}},{"id":1789237,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35140,"kind":"person","name":"Shawver Laura","position":1,"cik":"0001551891","reported_name":"Shawver Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-09-06T00:04:41.000Z","date":"2023-09-01","kind":"exercise","planned":true,"acquired":false,"shares":2997,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Immediately exercisable."}],"balance_after":0,"derivative":{"exercise_price":1.27,"expiration_date":"2030-04-28","underlying":"Common Stock","underlying_shares":2997},"source":{"system":"sec-edgar","filing":"0001209191-23-048254","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000120919123048254/doc4.xml","form_type":"4"}},{"id":1789236,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35140,"kind":"person","name":"Shawver Laura","position":1,"cik":"0001551891","reported_name":"Shawver Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-06T00:04:41.000Z","date":"2023-09-01","kind":"sale","planned":true,"acquired":false,"shares":100000,"price":7.7052,"value":770520.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 15, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $7.24 to $8.00, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth herein."}],"balance_after":210346,"source":{"system":"sec-edgar","filing":"0001209191-23-048254","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000120919123048254/doc4.xml","form_type":"4"}},{"id":1789235,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35140,"kind":"person","name":"Shawver Laura","position":1,"cik":"0001551891","reported_name":"Shawver Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-06T00:04:41.000Z","date":"2023-09-01","kind":"exercise","planned":true,"acquired":true,"shares":97003,"price":1.27,"value":123193.81,"ownership":{"direct":true},"balance_after":310346,"source":{"system":"sec-edgar","filing":"0001209191-23-048254","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000120919123048254/doc4.xml","form_type":"4"}},{"id":1789234,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35140,"kind":"person","name":"Shawver Laura","position":1,"cik":"0001551891","reported_name":"Shawver Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-06T00:04:41.000Z","date":"2023-09-01","kind":"exercise","planned":true,"acquired":true,"shares":2997,"price":1.27,"value":3806.19,"ownership":{"direct":true},"balance_after":213343,"source":{"system":"sec-edgar","filing":"0001209191-23-048254","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000120919123048254/doc4.xml","form_type":"4"}},{"id":1813846,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35140,"kind":"person","name":"Shawver Laura","position":1,"cik":"0001551891","reported_name":"Shawver Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-07T21:05:58.000Z","date":"2023-08-04","kind":"exercise","planned":true,"acquired":false,"shares":18897,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Immediately exercisable."}],"balance_after":2997,"derivative":{"exercise_price":1.27,"expiration_date":"2030-04-28","underlying":"Common Stock","underlying_shares":18897},"source":{"system":"sec-edgar","filing":"0001209191-23-044845","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000120919123044845/doc4.xml","form_type":"4"}},{"id":1813845,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35140,"kind":"person","name":"Shawver Laura","position":1,"cik":"0001551891","reported_name":"Shawver Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-07T21:05:58.000Z","date":"2023-08-03","kind":"exercise","planned":true,"acquired":false,"shares":26017,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Immediately exercisable."}],"balance_after":21894,"derivative":{"exercise_price":1.27,"expiration_date":"2030-04-28","underlying":"Common Stock","underlying_shares":26107},"source":{"system":"sec-edgar","filing":"0001209191-23-044845","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000120919123044845/doc4.xml","form_type":"4"}},{"id":1813844,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35140,"kind":"person","name":"Shawver Laura","position":1,"cik":"0001551891","reported_name":"Shawver Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-07T21:05:58.000Z","date":"2023-08-04","kind":"sale","planned":true,"acquired":false,"shares":18897,"price":7.0631,"value":133471.4007,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 15, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $6.96 to $7.22, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth herein."}],"balance_after":210346,"source":{"system":"sec-edgar","filing":"0001209191-23-044845","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000120919123044845/doc4.xml","form_type":"4"}},{"id":1813843,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35140,"kind":"person","name":"Shawver Laura","position":1,"cik":"0001551891","reported_name":"Shawver Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-07T21:05:58.000Z","date":"2023-08-04","kind":"exercise","planned":true,"acquired":true,"shares":18897,"price":1.27,"value":23999.19,"ownership":{"direct":true},"balance_after":229243,"source":{"system":"sec-edgar","filing":"0001209191-23-044845","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000120919123044845/doc4.xml","form_type":"4"}},{"id":1813842,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35140,"kind":"person","name":"Shawver Laura","position":1,"cik":"0001551891","reported_name":"Shawver Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-07T21:05:58.000Z","date":"2023-08-03","kind":"sale","planned":true,"acquired":false,"shares":26107,"price":7.0103,"value":183017.9021,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 15, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $6.90 to $7.10, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth herein."}],"balance_after":210346,"source":{"system":"sec-edgar","filing":"0001209191-23-044845","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000120919123044845/doc4.xml","form_type":"4"}},{"id":1813841,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35140,"kind":"person","name":"Shawver Laura","position":1,"cik":"0001551891","reported_name":"Shawver Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-07T21:05:58.000Z","date":"2023-08-03","kind":"exercise","planned":true,"acquired":true,"shares":26107,"price":1.27,"value":33155.89,"ownership":{"direct":true},"balance_after":236453,"source":{"system":"sec-edgar","filing":"0001209191-23-044845","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000120919123044845/doc4.xml","form_type":"4"}},{"id":1816398,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35140,"kind":"person","name":"Shawver Laura","position":1,"cik":"0001551891","reported_name":"Shawver Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-03T22:03:20.000Z","date":"2023-08-02","kind":"exercise","planned":true,"acquired":false,"shares":36281,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Immediately exercisable."}],"balance_after":48001,"derivative":{"exercise_price":1.27,"expiration_date":"2030-04-28","underlying":"Common Stock","underlying_shares":36281},"source":{"system":"sec-edgar","filing":"0001209191-23-044534","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000120919123044534/doc4.xml","form_type":"4"}},{"id":1816397,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35140,"kind":"person","name":"Shawver Laura","position":1,"cik":"0001551891","reported_name":"Shawver Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-03T22:03:20.000Z","date":"2023-08-01","kind":"exercise","planned":true,"acquired":false,"shares":18715,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Immediately exercisable."}],"balance_after":84282,"derivative":{"exercise_price":1.27,"expiration_date":"2030-04-28","underlying":"Common Stock","underlying_shares":18715},"source":{"system":"sec-edgar","filing":"0001209191-23-044534","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000120919123044534/doc4.xml","form_type":"4"}},{"id":1816396,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35140,"kind":"person","name":"Shawver Laura","position":1,"cik":"0001551891","reported_name":"Shawver Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-03T22:03:20.000Z","date":"2023-08-02","kind":"sale","planned":true,"acquired":false,"shares":36281,"price":7.0909,"value":257264.9429,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 15, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $6.95 to $7.23, inclusive. The Reporting Person undertakes to provide the the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth herein."}],"balance_after":210346,"source":{"system":"sec-edgar","filing":"0001209191-23-044534","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000120919123044534/doc4.xml","form_type":"4"}},{"id":1816395,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35140,"kind":"person","name":"Shawver Laura","position":1,"cik":"0001551891","reported_name":"Shawver Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-03T22:03:20.000Z","date":"2023-08-02","kind":"exercise","planned":true,"acquired":true,"shares":36281,"price":1.27,"value":46076.87,"ownership":{"direct":true},"balance_after":246627,"source":{"system":"sec-edgar","filing":"0001209191-23-044534","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000120919123044534/doc4.xml","form_type":"4"}},{"id":1816394,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35140,"kind":"person","name":"Shawver Laura","position":1,"cik":"0001551891","reported_name":"Shawver Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-03T22:03:20.000Z","date":"2023-08-01","kind":"sale","planned":true,"acquired":false,"shares":18715,"price":7.1908,"value":134575.822,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 15, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $7.11 to $7.33, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth herein."}],"balance_after":210346,"source":{"system":"sec-edgar","filing":"0001209191-23-044534","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000120919123044534/doc4.xml","form_type":"4"}},{"id":1816393,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35140,"kind":"person","name":"Shawver Laura","position":1,"cik":"0001551891","reported_name":"Shawver Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-03T22:03:20.000Z","date":"2023-08-01","kind":"exercise","planned":true,"acquired":true,"shares":18715,"price":1.27,"value":23768.05,"ownership":{"direct":true},"balance_after":229061,"source":{"system":"sec-edgar","filing":"0001209191-23-044534","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000120919123044534/doc4.xml","form_type":"4"}},{"id":1832925,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35140,"kind":"person","name":"Shawver Laura","position":1,"cik":"0001551891","reported_name":"Shawver Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-08T00:16:09.000Z","date":"2023-07-07","kind":"exercise","planned":false,"acquired":false,"shares":8858,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Immediately exercisable."}],"balance_after":102997,"derivative":{"exercise_price":1.27,"expiration_date":"2030-04-28","underlying":"Common Stock","underlying_shares":8858},"source":{"system":"sec-edgar","filing":"0001209191-23-041866","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000120919123041866/doc4.xml","form_type":"4"}},{"id":1832924,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35140,"kind":"person","name":"Shawver Laura","position":1,"cik":"0001551891","reported_name":"Shawver Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-07-08T00:16:09.000Z","date":"2023-07-07","kind":"sale","planned":false,"acquired":false,"shares":8858,"price":6.364,"value":56372.312,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 15, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $6.21 to $6.56, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth herein."}],"balance_after":210346,"source":{"system":"sec-edgar","filing":"0001209191-23-041866","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000120919123041866/doc4.xml","form_type":"4"}},{"id":1832923,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35140,"kind":"person","name":"Shawver Laura","position":1,"cik":"0001551891","reported_name":"Shawver Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-07-08T00:16:09.000Z","date":"2023-07-07","kind":"exercise","planned":false,"acquired":true,"shares":8858,"price":1.27,"value":11249.66,"ownership":{"direct":true},"balance_after":219204,"source":{"system":"sec-edgar","filing":"0001209191-23-041866","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000120919123041866/doc4.xml","form_type":"4"}},{"id":1833884,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35140,"kind":"person","name":"Shawver Laura","position":1,"cik":"0001551891","reported_name":"Shawver Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-07T00:55:41.000Z","date":"2023-07-06","kind":"exercise","planned":false,"acquired":false,"shares":33510,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Immediately exercisable."}],"balance_after":111855,"derivative":{"exercise_price":1.27,"expiration_date":"2030-04-28","underlying":"Common Stock","underlying_shares":33510},"source":{"system":"sec-edgar","filing":"0001209191-23-041716","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000120919123041716/doc4.xml","form_type":"4"}},{"id":1833883,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35140,"kind":"person","name":"Shawver Laura","position":1,"cik":"0001551891","reported_name":"Shawver Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-07T00:55:41.000Z","date":"2023-07-05","kind":"exercise","planned":false,"acquired":false,"shares":31112,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Immediately exercisable."}],"balance_after":145365,"derivative":{"exercise_price":1.27,"expiration_date":"2030-04-28","underlying":"Common Stock","underlying_shares":31112},"source":{"system":"sec-edgar","filing":"0001209191-23-041716","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000120919123041716/doc4.xml","form_type":"4"}},{"id":1833882,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35140,"kind":"person","name":"Shawver Laura","position":1,"cik":"0001551891","reported_name":"Shawver Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-07T00:55:41.000Z","date":"2023-07-03","kind":"exercise","planned":false,"acquired":false,"shares":26520,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Immediately exercisable."}],"balance_after":176477,"derivative":{"exercise_price":1.27,"expiration_date":"2030-04-28","underlying":"Common Stock","underlying_shares":26520},"source":{"system":"sec-edgar","filing":"0001209191-23-041716","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000120919123041716/doc4.xml","form_type":"4"}},{"id":1833881,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35140,"kind":"person","name":"Shawver Laura","position":1,"cik":"0001551891","reported_name":"Shawver Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-07-07T00:55:41.000Z","date":"2023-07-06","kind":"sale","planned":false,"acquired":false,"shares":33510,"price":6.343,"value":212553.93,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 15, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $6.10 to $6.45, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth herein."}],"balance_after":210346,"source":{"system":"sec-edgar","filing":"0001209191-23-041716","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000120919123041716/doc4.xml","form_type":"4"}},{"id":1833880,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35140,"kind":"person","name":"Shawver Laura","position":1,"cik":"0001551891","reported_name":"Shawver Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-07-07T00:55:41.000Z","date":"2023-07-06","kind":"exercise","planned":false,"acquired":true,"shares":33510,"price":1.27,"value":42557.7,"ownership":{"direct":true},"balance_after":243856,"source":{"system":"sec-edgar","filing":"0001209191-23-041716","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000120919123041716/doc4.xml","form_type":"4"}},{"id":1833879,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35140,"kind":"person","name":"Shawver Laura","position":1,"cik":"0001551891","reported_name":"Shawver Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-07-07T00:55:41.000Z","date":"2023-07-05","kind":"sale","planned":false,"acquired":false,"shares":31112,"price":6.414,"value":199552.368,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 15, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $6.21 to $6.75, inclusive. The Reporting Person undertakes to provide the the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth herein."}],"balance_after":210346,"source":{"system":"sec-edgar","filing":"0001209191-23-041716","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000120919123041716/doc4.xml","form_type":"4"}},{"id":1833878,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35140,"kind":"person","name":"Shawver Laura","position":1,"cik":"0001551891","reported_name":"Shawver Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-07-07T00:55:41.000Z","date":"2023-07-05","kind":"exercise","planned":false,"acquired":true,"shares":31112,"price":1.27,"value":39512.24,"ownership":{"direct":true},"balance_after":241458,"source":{"system":"sec-edgar","filing":"0001209191-23-041716","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000120919123041716/doc4.xml","form_type":"4"}},{"id":1833877,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35140,"kind":"person","name":"Shawver Laura","position":1,"cik":"0001551891","reported_name":"Shawver Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-07-07T00:55:41.000Z","date":"2023-07-03","kind":"sale","planned":false,"acquired":false,"shares":26520,"price":6.725,"value":178347.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 15, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $6.62 to $6.81, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth herein."}],"balance_after":210346,"source":{"system":"sec-edgar","filing":"0001209191-23-041716","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000120919123041716/doc4.xml","form_type":"4"}},{"id":1833876,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35140,"kind":"person","name":"Shawver Laura","position":1,"cik":"0001551891","reported_name":"Shawver Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-07-07T00:55:41.000Z","date":"2023-07-03","kind":"exercise","planned":false,"acquired":true,"shares":26520,"price":1.27,"value":33680.4,"ownership":{"direct":true},"balance_after":236866,"source":{"system":"sec-edgar","filing":"0001209191-23-041716","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000120919123041716/doc4.xml","form_type":"4"}},{"id":1842702,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35140,"kind":"person","name":"Shawver Laura","position":1,"cik":"0001551891","reported_name":"Shawver Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-29T01:00:34.000Z","date":"2023-06-27","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest in full on the earlier of June 27, 2024 or the date of the Issuer's 2024 annual meeting of stockholders, which date has not been set by the Issuer's Board of Directors."}],"balance_after":40000,"derivative":{"exercise_price":6.5,"expiration_date":"2033-06-26","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-23-040110","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000120919123040110/doc4.xml","form_type":"4"}},{"id":1869915,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35140,"kind":"person","name":"Shawver Laura","position":1,"cik":"0001551891","reported_name":"Shawver Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-02T23:48:08.000Z","date":"2023-06-02","kind":"exercise","planned":true,"acquired":false,"shares":26941,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Immediately exercisable."}],"balance_after":202997,"derivative":{"exercise_price":1.27,"expiration_date":"2030-04-28","underlying":"Common Stock","underlying_shares":26941},"source":{"system":"sec-edgar","filing":"0001209191-23-034090","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000120919123034090/doc4.xml","form_type":"4"}},{"id":1869914,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35140,"kind":"person","name":"Shawver Laura","position":1,"cik":"0001551891","reported_name":"Shawver Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-02T23:48:08.000Z","date":"2023-06-01","kind":"exercise","planned":true,"acquired":false,"shares":73059,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Immediately exercisable."}],"balance_after":229938,"derivative":{"exercise_price":1.27,"expiration_date":"2030-04-28","underlying":"Common Stock","underlying_shares":73059},"source":{"system":"sec-edgar","filing":"0001209191-23-034090","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000120919123034090/doc4.xml","form_type":"4"}},{"id":1869913,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35140,"kind":"person","name":"Shawver Laura","position":1,"cik":"0001551891","reported_name":"Shawver Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-02T23:48:08.000Z","date":"2023-06-02","kind":"sale","planned":true,"acquired":false,"shares":26941,"price":6.95,"value":187239.95,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 15, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions ranging from $6.73 to $7.22, inclusive.  The Reporting Person undertakes to provide the the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth herein."}],"balance_after":210346,"source":{"system":"sec-edgar","filing":"0001209191-23-034090","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000120919123034090/doc4.xml","form_type":"4"}},{"id":1869912,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35140,"kind":"person","name":"Shawver Laura","position":1,"cik":"0001551891","reported_name":"Shawver Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-02T23:48:08.000Z","date":"2023-06-02","kind":"exercise","planned":true,"acquired":true,"shares":26941,"price":1.27,"value":34215.07,"ownership":{"direct":true},"balance_after":237287,"source":{"system":"sec-edgar","filing":"0001209191-23-034090","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000120919123034090/doc4.xml","form_type":"4"}},{"id":1869911,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35140,"kind":"person","name":"Shawver Laura","position":1,"cik":"0001551891","reported_name":"Shawver Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-02T23:48:08.000Z","date":"2023-06-01","kind":"sale","planned":true,"acquired":false,"shares":73059,"price":6.8,"value":496801.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 15, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions ranging from $6.60 to $7.07, inclusive.  The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth herein."}],"balance_after":210346,"source":{"system":"sec-edgar","filing":"0001209191-23-034090","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000120919123034090/doc4.xml","form_type":"4"}},{"id":1869910,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35140,"kind":"person","name":"Shawver Laura","position":1,"cik":"0001551891","reported_name":"Shawver Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-02T23:48:08.000Z","date":"2023-06-01","kind":"exercise","planned":true,"acquired":true,"shares":73059,"price":1.27,"value":92784.93,"ownership":{"direct":true},"balance_after":283405,"source":{"system":"sec-edgar","filing":"0001209191-23-034090","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000120919123034090/doc4.xml","form_type":"4"}},{"id":1872169,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":35140,"kind":"person","name":"Shawver Laura","position":1,"cik":"0001551891","reported_name":"Shawver Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-01T22:31:33.000Z","date":"2023-05-31","kind":"grant","planned":false,"acquired":true,"shares":66055,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on May 31, 2023 with respect to 66,055 shares of the Issuer's common stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the grant date."}],"balance_after":66055,"derivative":{"exercise_price":11.14,"expiration_date":"2033-05-30","underlying":"Common Stock","underlying_shares":66055},"source":{"system":"sec-edgar","filing":"0001209191-23-033432","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000120919123033432/doc4.xml","form_type":"4"}},{"id":1876695,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":35140,"kind":"person","name":"Shawver Laura","position":1,"cik":"0001551891","reported_name":"Shawver Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-26T20:14:04.000Z","date":"2023-05-24","kind":"gift","planned":false,"acquired":false,"shares":12099,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects the gift of common stock to a charitable foundation."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Price is not applicable to acquisitions or dispositions resulting from bona fide gifts."}],"balance_after":40000,"source":{"system":"sec-edgar","filing":"0001209191-23-032515","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000120919123032515/doc4.xml","form_type":"4"}},{"id":1898171,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35140,"kind":"person","name":"Shawver Laura","position":1,"cik":"0001551891","reported_name":"Shawver Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-10T20:53:46.000Z","date":"2023-05-09","kind":"exercise","planned":true,"acquired":false,"shares":42900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Immediately exercisable."}],"balance_after":302997,"derivative":{"exercise_price":1.27,"expiration_date":"2030-04-28","underlying":"Common Stock","underlying_shares":42900},"source":{"system":"sec-edgar","filing":"0001209191-23-028507","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000120919123028507/doc4.xml","form_type":"4"}},{"id":1898170,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35140,"kind":"person","name":"Shawver Laura","position":1,"cik":"0001551891","reported_name":"Shawver Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-10T20:53:46.000Z","date":"2023-05-08","kind":"exercise","planned":true,"acquired":false,"shares":57100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Immediately exercisable."}],"balance_after":345897,"derivative":{"exercise_price":1.27,"expiration_date":"2030-04-28","underlying":"Common Stock","underlying_shares":57100},"source":{"system":"sec-edgar","filing":"0001209191-23-028507","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000120919123028507/doc4.xml","form_type":"4"}},{"id":1898169,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35140,"kind":"person","name":"Shawver Laura","position":1,"cik":"0001551891","reported_name":"Shawver Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-10T20:53:46.000Z","date":"2023-05-09","kind":"sale","planned":true,"acquired":false,"shares":42900,"price":5.31,"value":227799.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sales reported on this Form 4 were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 15, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price.  These shares were purchased in multiple transactions ranging from $5.00 to $5.92, inclusive.  The Reporting Person undertakes to provide the the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth herein."}],"balance_after":210346,"source":{"system":"sec-edgar","filing":"0001209191-23-028507","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000120919123028507/doc4.xml","form_type":"4"}},{"id":1898168,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35140,"kind":"person","name":"Shawver Laura","position":1,"cik":"0001551891","reported_name":"Shawver Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-10T20:53:46.000Z","date":"2023-05-09","kind":"exercise","planned":true,"acquired":true,"shares":42900,"price":1.27,"value":54483.0,"ownership":{"direct":true},"balance_after":253246,"source":{"system":"sec-edgar","filing":"0001209191-23-028507","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000120919123028507/doc4.xml","form_type":"4"}},{"id":1898167,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35140,"kind":"person","name":"Shawver Laura","position":1,"cik":"0001551891","reported_name":"Shawver Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-10T20:53:46.000Z","date":"2023-05-08","kind":"sale","planned":true,"acquired":false,"shares":57100,"price":6.16,"value":351736.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sales reported on this Form 4 were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 15, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price.  These shares were purchased in multiple transactions ranging from $6.00 to $6.44, inclusive.  The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth herein."}],"balance_after":210346,"source":{"system":"sec-edgar","filing":"0001209191-23-028507","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000120919123028507/doc4.xml","form_type":"4"}},{"id":1898166,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35140,"kind":"person","name":"Shawver Laura","position":1,"cik":"0001551891","reported_name":"Shawver Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-10T20:53:46.000Z","date":"2023-05-08","kind":"exercise","planned":true,"acquired":true,"shares":57100,"price":1.27,"value":72517.0,"ownership":{"direct":true},"balance_after":267446,"source":{"system":"sec-edgar","filing":"0001209191-23-028507","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000120919123028507/doc4.xml","form_type":"4"}},{"id":1898165,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35140,"kind":"person","name":"Shawver Laura","position":1,"cik":"0001551891","reported_name":"Shawver Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-10T20:53:46.000Z","date":"2022-11-09","kind":"sale","planned":true,"acquired":false,"shares":43896,"price":4.58,"value":201043.68,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold to satisfy estimated tax withholding obligations upon the settlement of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price.  These shares were purchased in multiple transactions ranging from $4.53 to $5.31, inclusive.  The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth herein."}],"balance_after":210346,"source":{"system":"sec-edgar","filing":"0001209191-23-028507","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000120919123028507/doc4.xml","form_type":"4"}},{"id":2190881,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35140,"kind":"person","name":"Shawver Laura","position":1,"cik":"0001551891","reported_name":"Shawver Laura","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock option (right to buy)","published_at":"2022-08-09T20:38:07.000Z","date":"2022-08-05","kind":"exercise","acquired":false,"shares":78740,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares vested on April 16, 2021 and the remaining shares shall vest in 36 equal monthly installments thereafter."}],"balance_after":402997,"derivative":{"exercise_price":1.27,"expiration_date":"2030-04-28","underlying":"Common Stock","underlying_shares":78740},"source":{"system":"sec-edgar","filing":"0001209191-22-045023","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000120919122045023/doc4.xml","form_type":"4"}},{"id":2190880,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35140,"kind":"person","name":"Shawver Laura","position":1,"cik":"0001551891","reported_name":"Shawver Laura","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-08-09T20:38:07.000Z","date":"2022-08-05","kind":"exercise","acquired":true,"shares":78740,"price":1.27,"value":99999.8,"ownership":{"direct":true},"balance_after":254242,"source":{"system":"sec-edgar","filing":"0001209191-22-045023","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000120919122045023/doc4.xml","form_type":"4"}},{"id":2235464,"issuer":{"id":6346,"kind":"organization","name":"Nkarta, Inc."},"owners":[{"id":35140,"kind":"person","name":"Shawver Laura","position":1,"cik":"0001551891","reported_name":"Shawver Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-10T20:10:48.000Z","date":"2022-06-08","kind":"grant","acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All shares subject to the option vest 100% on the first to occur of (i) June 8, 2023 or (ii) the day immediately preceding the first annual meeting of the Issuer's stockholders to occur after the date of grant of the award. Each grant, to the extent outstanding and otherwise unvested, will become fully vested should a \"change in control\" of the Issuer occur (as described in the applicable award agreement) or upon the Reporting Person's separation from service with the Issuer due to the Reporting Person's death or \"disability\" (as described in the applicable award agreement)."}],"balance_after":16000,"derivative":{"exercise_price":14.95,"expiration_date":"2032-06-07","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001209191-22-035844","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551891/000120919122035844/doc4.xml","form_type":"4"}},{"id":2253659,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":35140,"kind":"person","name":"Shawver Laura","position":1,"cik":"0001551891","reported_name":"Shawver Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-27T21:35:29.000Z","date":"2022-05-27","kind":"grant","acquired":true,"shares":41597,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on May 27, 2022 with respect to 41,597 shares of the Issuer's common stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the grant date."}],"balance_after":41597,"derivative":{"exercise_price":17.33,"expiration_date":"2032-05-26","underlying":"Common Stock","underlying_shares":41597},"source":{"system":"sec-edgar","filing":"0001209191-22-032674","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000120919122032674/doc4.xml","form_type":"4"}},{"id":2282326,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35140,"kind":"person","name":"Shawver Laura","position":1,"cik":"0001551891","reported_name":"Shawver Laura","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-05-04T21:19:18.000Z","date":"2022-05-02","kind":"grant","acquired":true,"shares":136214,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest on May 2, 2023."}],"balance_after":136214,"derivative":{"exercise_price":3.15,"expiration_date":"2032-05-01","underlying":"Common Stock","underlying_shares":136214},"source":{"system":"sec-edgar","filing":"0001209191-22-027168","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000120919122027168/doc4.xml","form_type":"4"}},{"id":2282325,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35140,"kind":"person","name":"Shawver Laura","position":1,"cik":"0001551891","reported_name":"Shawver Laura","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-05-04T21:19:18.000Z","date":"2022-05-02","kind":"grant","acquired":true,"shares":68107,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares being reported are being issued pursuant to restricted stock units, each one of which represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":175502,"source":{"system":"sec-edgar","filing":"0001209191-22-027168","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000120919122027168/doc4.xml","form_type":"4"}},{"id":2416713,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35140,"kind":"person","name":"Shawver Laura","position":1,"cik":"0001551891","reported_name":"Shawver Laura","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-02-02T22:17:10.000Z","date":"2022-02-01","kind":"grant","acquired":true,"shares":104500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the shares subject to the option vest on February 1, 2023, and the remaining shares will vest monthly thereafter over three years."}],"balance_after":104500,"derivative":{"exercise_price":4.85,"expiration_date":"2032-01-31","underlying":"Common Stock","underlying_shares":104500},"source":{"system":"sec-edgar","filing":"0001209191-22-006435","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000120919122006435/doc4.xml","form_type":"4"}},{"id":2416712,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35140,"kind":"person","name":"Shawver Laura","position":1,"cik":"0001551891","reported_name":"Shawver Laura","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-02-02T22:17:10.000Z","date":"2022-02-01","kind":"grant","acquired":true,"shares":165000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option vest in equal monthly installments over the 48 months following February 1, 2022."}],"balance_after":165000,"derivative":{"exercise_price":4.85,"expiration_date":"2032-01-31","underlying":"Common Stock","underlying_shares":165000},"source":{"system":"sec-edgar","filing":"0001209191-22-006435","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000120919122006435/doc4.xml","form_type":"4"}},{"id":2416711,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35140,"kind":"person","name":"Shawver Laura","position":1,"cik":"0001551891","reported_name":"Shawver Laura","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-02-02T22:17:10.000Z","date":"2022-02-01","kind":"grant","acquired":true,"shares":27500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares being reported are being issued pursuant to restricted stock units, each one of which represents a contingent right to receive one share of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 682 shares acquired under the Issuer's 2020 Employee Stock Purchase Plan on June 30, 2021."}],"balance_after":107395,"source":{"system":"sec-edgar","filing":"0001209191-22-006435","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000120919122006435/doc4.xml","form_type":"4"}},{"id":2667679,"issuer":{"id":6346,"kind":"organization","name":"Nkarta, Inc."},"owners":[{"id":35140,"kind":"person","name":"Shawver Laura","position":1,"cik":"0001551891","reported_name":"Shawver Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-15T14:25:38.000Z","date":"2021-06-13","kind":"grant","acquired":true,"shares":16511,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All shares subject to the option vest 100% on the first to occur of (i) June 13, 2022, or (ii) the day immediately preceding the first annual meeting of the Issuer's stockholders to occur after the date of grant of the award. Each grant, to the extent outstanding and otherwise unvested, will become fully vested should a \"change in control\" of the Issuer occur (as described in the applicable award agreement) or upon the Reporting Person's separation from service with the Issuer due to the Reporting Person's death or \"disability\" (as described in the applicable award agreement)."}],"balance_after":16511,"derivative":{"exercise_price":25.03,"expiration_date":"2031-06-12","underlying":"Common Stock","underlying_shares":16511},"source":{"system":"sec-edgar","filing":"0000899243-21-023797","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551891/000089924321023797/doc4.xml","form_type":"4"}},{"id":2701073,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":35140,"kind":"person","name":"Shawver Laura","position":1,"cik":"0001551891","reported_name":"Shawver Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-21T23:46:44.000Z","date":"2021-05-19","kind":"grant","acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on May 19, 2021 with respect to 16,000 shares of the Issuer's common stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the grant date."}],"balance_after":16000,"derivative":{"exercise_price":30.09,"expiration_date":"2031-05-18","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001209191-21-035116","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000120919121035116/doc4.xml","form_type":"4"}},{"id":2955221,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35140,"kind":"person","name":"Shawver Laura","position":1,"cik":"0001551891","reported_name":"Shawver Laura","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-12-08T00:59:32.000Z","date":"2020-12-03","kind":"grant","acquired":true,"shares":562631,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in equal monthly installments over the 48 months following December 3, 2020."}],"balance_after":562631,"derivative":{"exercise_price":21,"expiration_date":"2030-12-02","underlying":"Common Stock","underlying_shares":562631},"source":{"system":"sec-edgar","filing":"0001209191-20-062053","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000120919120062053/doc4.xml","form_type":"4"}},{"id":3084162,"issuer":{"id":6346,"kind":"organization","name":"Nkarta, Inc."},"owners":[{"id":35140,"kind":"person","name":"Shawver Laura","position":1,"cik":"0001551891","reported_name":"Shawver Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-07-14T01:45:08.000Z","date":"2020-07-09","kind":"grant","acquired":true,"shares":18300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All shares subject to the option vest 100% on the first anniversary of July 1, 2020, or, if earlier, on the day immediately preceding the first annual meeting of the Issuer's stockholders in 2021 at which one or more members of the Issuer's board of directors are to be elected. Each grant, to the extent outstanding and otherwise unvested, will become fully vest should a \"change in control\" of the Issuer occur (as defined in the applicable award agreement) or upon the Reporting Person's separation from service with the Issuer due to the Reporting Person's death or \"disability\" (as defined in the applicable award agreement)."}],"balance_after":18300,"derivative":{"exercise_price":18,"expiration_date":"2030-07-08","underlying":"Common Stock","underlying_shares":18300},"source":{"system":"sec-edgar","filing":"0000899243-20-019029","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1551891/000089924320019029/doc4.xml","form_type":"4"}},{"id":3084161,"issuer":{"id":6346,"kind":"organization","name":"Nkarta, Inc."},"owners":[{"id":35140,"kind":"person","name":"Shawver Laura","position":1,"cik":"0001551891","reported_name":"Shawver Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-07-14T01:45:08.000Z","date":"2020-07-09","kind":"grant","acquired":true,"shares":10700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All shares subject to the option vest 100% on the first anniversary of July 9, 2020, or, if earlier, on the day immediately preceding the first annual meeting of the Issuer's stockholders in 2021 at which one or more members of the Issuer's board of directors are to be elected. Each grant, to the extent outstanding and otherwise unvested, will become fully vest should a \"change in control\" of the Issuer occur (as described in the applicable award agreement) or upon the Reporting Person's separation from service with the Issuer due to the Reporting Person's death or \"disability\" (as described in the applicable award agreement)."}],"balance_after":10700,"derivative":{"exercise_price":18,"expiration_date":"2030-07-08","underlying":"Common Stock","underlying_shares":10700},"source":{"system":"sec-edgar","filing":"0000899243-20-019029","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551891/000089924320019029/doc4.xml","form_type":"4"}},{"id":3302511,"issuer":{"id":152202,"kind":"organization","name":"Synthorx, Inc.","symbol":"THOR"},"owners":[{"id":35140,"kind":"person","name":"Shawver Laura","position":1,"cik":"0001551891","reported_name":"Shawver Laura","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-01-24T23:41:27.000Z","date":"2020-01-23","kind":"disposition_to_issuer","acquired":false,"shares":385185,"price":57,"value":21955545.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option, which provided for vesting of 33.333% of the shares on December 18, 2019, with 66.667% of the shares subject to the option vesting upon certification by the Compensation Committee of the Board of Directors of the Issuer that the Issuer has received the first approval for commercial sale by a regulatory authority of any product candidate of the Issuer in any territory in the world, was cancelled in connection with the merger of the Issuer with Sanofi's wholly owned subsidiary in exchange for a cash payment of $21,955,545.00, representing the difference between the exercise price of the option and the market value of the underlying common stock of the Issuer on the effective date of the merger ($68)."}],"balance_after":0,"derivative":{"exercise_price":11,"expiration_date":"2028-12-05","underlying":"Common Stock","underlying_shares":385185},"source":{"system":"sec-edgar","filing":"0001209191-20-004929","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1551891/000120919120004929/doc4.xml","form_type":"4"}},{"id":3302510,"issuer":{"id":152202,"kind":"organization","name":"Synthorx, Inc.","symbol":"THOR"},"owners":[{"id":35140,"kind":"person","name":"Shawver Laura","position":1,"cik":"0001551891","reported_name":"Shawver Laura","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-01-24T23:41:27.000Z","date":"2020-01-23","kind":"disposition_to_issuer","acquired":false,"shares":172264,"price":67.37,"value":11605425.68,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option, which provided for vesting of 25% of the shares one year after November 27, 2017, with the balance vesting in equal monthly installments thereafter over the next 36 months, was cancelled in connection with the merger of the Issuer with Sanofi's wholly owned subsidiary in exchange for a cash payment of $11,605,425.68, representing the difference between the exercise price of the option and the market value of the underlying common stock of the Issuer on the effective date of the merger ($68)."}],"balance_after":0,"derivative":{"exercise_price":0.63,"expiration_date":"2027-12-06","underlying":"Common Stock","underlying_shares":172264},"source":{"system":"sec-edgar","filing":"0001209191-20-004929","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1551891/000120919120004929/doc4.xml","form_type":"4"}},{"id":3302509,"issuer":{"id":152202,"kind":"organization","name":"Synthorx, Inc.","symbol":"THOR"},"owners":[{"id":35140,"kind":"person","name":"Shawver Laura","position":1,"cik":"0001551891","reported_name":"Shawver Laura","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-01-24T23:41:27.000Z","date":"2020-01-23","kind":"disposition_to_issuer","acquired":false,"shares":293177,"price":67.07,"value":19663381.39,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option, which provided for vesting of 27,695 shares on April 12, 2019, with the remaining 363,944 shares vesting in equal monthly installments thereafter over the next 36 months, was cancelled in connection with the merger of the Issuer with Sanofi's wholly owned subsidiary in exchange for a cash payment of $19,663,381.39, representing the difference between the exercise price of the option and the market value of the underlying common stock of the Issuer on the effective date of the merger ($68)."}],"balance_after":0,"derivative":{"exercise_price":0.93,"expiration_date":"2028-05-16","underlying":"Common Stock","underlying_shares":293177},"source":{"system":"sec-edgar","filing":"0001209191-20-004929","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1551891/000120919120004929/doc4.xml","form_type":"4"}},{"id":3302508,"issuer":{"id":152202,"kind":"organization","name":"Synthorx, Inc.","symbol":"THOR"},"owners":[{"id":35140,"kind":"person","name":"Shawver Laura","position":1,"cik":"0001551891","reported_name":"Shawver Laura","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-01-24T23:41:27.000Z","date":"2020-01-23","kind":"other","acquired":false,"shares":25000,"price":68,"value":1700000.0,"ownership":{"direct":false,"nature":"By Laura K. Shawver Trust DTD 3/20/2000"},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-20-004929","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1551891/000120919120004929/doc4.xml","form_type":"4"}}],"next_cursor":"2020-01-24T23:41:27.000000Z,3302508"}